SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $482,039 | -75.9% | 803,891 | -47.9% | 0.00% | -100.0% |
| Q2 2023 | $2,003,799 | -65.5% | 1,541,620 | -53.3% | 0.00% | -50.0% |
| Q1 2023 | $5,813,512 | +53654.2% | 3,303,357 | -4.1% | 0.00% | -33.3% |
| Q4 2022 | $10,815 | -99.9% | 3,444,283 | +12.2% | 0.00% | -50.0% |
| Q3 2022 | $15,047,000 | +17.9% | 3,070,841 | -0.4% | 0.01% | +20.0% |
| Q2 2022 | $12,766,000 | -22.7% | 3,083,627 | +8.5% | 0.01% | 0.0% |
| Q1 2022 | $16,506,000 | -1.2% | 2,840,893 | +27.6% | 0.01% | 0.0% |
| Q4 2021 | $16,700,000 | -20.0% | 2,226,467 | -3.9% | 0.01% | -28.6% |
| Q3 2021 | $20,870,000 | -42.0% | 2,316,207 | -23.0% | 0.01% | -36.4% |
| Q2 2021 | $35,986,000 | +8.2% | 3,006,478 | +13.2% | 0.01% | 0.0% |
| Q1 2021 | $33,255,000 | -9.6% | 2,655,377 | +12.7% | 0.01% | -15.4% |
| Q4 2020 | $36,772,000 | +69.6% | 2,356,055 | +2.7% | 0.01% | +44.4% |
| Q3 2020 | $21,679,000 | +7.2% | 2,293,798 | +1.6% | 0.01% | 0.0% |
| Q2 2020 | $20,229,000 | +44.5% | 2,257,888 | +2.8% | 0.01% | +28.6% |
| Q1 2020 | $13,995,000 | -23.5% | 2,196,935 | +0.6% | 0.01% | 0.0% |
| Q4 2019 | $18,284,000 | -4.9% | 2,184,582 | +2.8% | 0.01% | 0.0% |
| Q3 2019 | $19,224,000 | -8.9% | 2,124,184 | +8.5% | 0.01% | -12.5% |
| Q2 2019 | $21,091,000 | +45.8% | 1,958,404 | +29.1% | 0.01% | +33.3% |
| Q1 2019 | $14,468,000 | +1.7% | 1,516,660 | +22.4% | 0.01% | 0.0% |
| Q4 2018 | $14,224,000 | +278.8% | 1,239,110 | +459.3% | 0.01% | +500.0% |
| Q3 2018 | $3,755,000 | -14.2% | 221,537 | -3.8% | 0.00% | -50.0% |
| Q1 2018 | $4,375,000 | +15.9% | 230,252 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,776,000 | +7.7% | 230,252 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $3,506,000 | +70.4% | 233,752 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $2,057,000 | +207.0% | 233,752 | +81.5% | 0.00% | – |
| Q1 2017 | $670,000 | +71.4% | 128,764 | +0.4% | 0.00% | – |
| Q4 2016 | $391,000 | -28.0% | 128,251 | +9.3% | 0.00% | – |
| Q3 2016 | $543,000 | -15.7% | 117,374 | +5.6% | 0.00% | – |
| Q2 2016 | $644,000 | +7.3% | 111,174 | +12.1% | 0.00% | – |
| Q1 2016 | $600,000 | +3233.3% | 99,210 | +8321.9% | 0.00% | – |
| Q4 2014 | $18,000 | +38.5% | 1,178 | 0.0% | 0.00% | – |
| Q3 2014 | $13,000 | -99.2% | 1,178 | -98.9% | 0.00% | -100.0% |
| Q2 2014 | $1,647,000 | -18.5% | 107,831 | -3.5% | 0.00% | -50.0% |
| Q1 2014 | $2,020,000 | +30.7% | 111,731 | +0.4% | 0.00% | +100.0% |
| Q4 2013 | $1,545,000 | -41.3% | 111,253 | -55.7% | 0.00% | -50.0% |
| Q3 2013 | $2,633,000 | -19.3% | 251,282 | -39.8% | 0.00% | -33.3% |
| Q2 2013 | $3,261,000 | – | 417,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |